Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Castor zinc finger protein 1 (CASZ1) is a zinc finger transcription factor that functions as a transcriptional activator, regulating the expression of target genes involved in blood vessel formation (vascular assembly and morphogenesis) and other processes[1][2][5]. It is encoded by the CASZ1 gene and may act as a tumor suppressor[1]. Variants in the CASZ1 gene are associated with blood pressure variation and have been implicated in specific disease states such as dilated cardiomyopathy and chromosome 1p36 deletion syndrome[1]. CASZ1’s molecular functions include DNA binding and metal ion binding, consistent with its role as a DNA-binding transcription factor[3][5]. There is no evidence that CASZ1 is a direct target for currently approved drugs, nor are there reported biomarkers or pharmacological mechanism of action terms specifically linked to drugs targeting this protein[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Castor zinc finger protein 1 (CASZ1).